Evidence of Endogenous Mu Opioid Receptor Regulation by Epigenetic Control of the Promoters

REFERENCES

• Azaryan, A. V., B. J. Clock, J. G. Rosenberger, and B. M. Cox. 1998. Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can. J. Physiol. Pharmacol. 76:278–283.
   PubMed Web of Science ®Google Scholar
• Bader, S., M. Walker, B. Hendrich, A. Bird, C. Bird, M. Hooper, and A. Wyllie. 1999. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 18:8044–8047.
   PubMedGoogle Scholar
• Berger, S. L. 2001. An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene 20:3007–3013.
   PubMed Web of Science ®Google Scholar
• Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16:6–21.
   PubMed Web of Science ®Google Scholar
• Bohn, L. M., M. M. Belcheva, and C. J. Coscia. 1998. Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells. J. Neurochem. 70:1819–1825.
   PubMedGoogle Scholar
• Boyes, J., and A. Bird. 1991. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64:1123–1134.
   PubMed Web of Science ®Google Scholar
• Chan, Y., J. E. Fish, C. D'Abreo, S. Lin, G. B. Robb, A. M. Teichert, F. Karantzoulis-Fegaras, A. Keightley, B. M. Steer, and P. A. Marsden. 2004. The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J. Biol. Chem. 279:35087–35100.
   PubMed Web of Science ®Google Scholar
• Chang, S. L., B. Felix, Y. Jiang, and M. Fiala. 2001. Actions of endotoxin and morphine. Adv. Exp. Med. Biol. 493:187–196.
   PubMedGoogle Scholar
• Chen, H. C., and H. H. Loh. 2001. μ-Opioid receptor gene expression: the role of NCAM. Neuroscience 108:7–15.
   PubMedGoogle Scholar
• Chen, H. C., L. N. Wei, and H. H. Loh. 1999. Expression of mu-, kappa- and delta-opioid receptors in P19 mouse embryonal carcinoma cells. Neuroscience 92:1143–1155.
   PubMed Web of Science ®Google Scholar
• Chen, W. G., Q. Chang, Y. Lin, A. Meissner, A. E. West, E. C. Griffith, R. Jaenisch, and M. E. Greenberg. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885–889.
   PubMed Web of Science ®Google Scholar
• Choi, H. S., C. K. Hwang, C. S. Kim, K. Y. Song, P. Y. Law, L. N. Wei, and H. H. Loh. 2005. Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene. Mol. Pharmacol. 67:1674–1683.
   PubMedGoogle Scholar
• Christman, J. K. 2002. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21:5483–5495.
   PubMed Web of Science ®Google Scholar
• Delfs, J. M., L. Yu, G. D. Ellison, T. Reisine, and M. F. Chesselet. 1994. Regulation of mu-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration. J. Neurochem. 63:777–780.
   PubMedGoogle Scholar
• Detich, N., V. Bovenzi, and M. Szyf. 2003. Valproate induces replication-independent active DNA demethylation. J. Biol. Chem. 278:27586–27592.
   PubMed Web of Science ®Google Scholar
• Drewell, R. A., C. J. Goddard, J. O. Thomas, and M. A. Surani. 2002. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Res. 30:1139–1144.
   PubMedGoogle Scholar
• Fish, J. E., C. C. Matouk, A. Rachlis, S. Lin, S. C. Tai, C. D'Abreo, and P. A. Marsden. 2005. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J. Biol. Chem. 280:24824–24838.
   PubMed Web of Science ®Google Scholar
• Fujita, N., S. Watanabe, T. Ichimura, S. Tsuruzoe, Y. Shinkai, M. Tachibana, T. Chiba, and M. Nakao. 2003. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J. Biol. Chem. 278:24132–24138.
   PubMed Web of Science ®Google Scholar
• Fuks, F., P. J. Hurd, D. Wolf, X. Nan, A. P. Bird, and T. Kouzarides. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278:4035–4040.
   PubMed Web of Science ®Google Scholar
• Gao, X., W. Bian, J. Yang, K. Tang, H. Kitani, T. Atsumi, and N. Jing. 2001. A role of N-cadherin in neuronal differentiation of embryonic carcinoma P19 cells. Biochem. Biophys. Res. Commun. 284:1098–1103.
   PubMedGoogle Scholar
• Georgel, P. T., R. A. Horowitz-Scherer, N. Adkins, C. L. Woodcock, P. A. Wade, and J. C. Hansen. 2003. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278:32181–32188.
   PubMed Web of Science ®Google Scholar
• Gies, E. K., D. M. Peters, C. R. Gelb, K. M. Knag, and R. A. Peterfreund. 1997. Regulation of mu opioid receptor mRNA levels by activation of protein kinase C in human SH-SY5Y neuroblastoma cells. Anesthesiology 87:1127–1138.
   PubMedGoogle Scholar
• Gilsbach, R., M. Kouta, H. Bonisch, and M. Bruss. 2006. Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. BioTechniques 40:173–177.
   PubMed Web of Science ®Google Scholar
• Gregory, R. I., T. E. Randall, C. A. Johnson, S. Khosla, I. Hatada, L. P. O'Neill, B. M. Turner, and R. Feil. 2001. DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol. Cell. Biol. 21:5426–5436.
   PubMed Web of Science ®Google Scholar
• Gruenbaum, Y., R. Stein, H. Cedar, and A. Razin. 1981. Methylation of CpG sequences in eukaryotic DNA. FEBS Lett. 124:67–71.
   PubMed Web of Science ®Google Scholar
• Hamada-Kanazawa, M., K. Ishikawa, K. Nomoto, T. Uozumi, Y. Kawai, M. Narahara, and M. Miyake. 2004. Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid. FEBS Lett. 560:192–198.
   PubMedGoogle Scholar
• Hendrich, B., C. Abbott, H. McQueen, D. Chambers, S. Cross, and A. Bird. 1999. Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm. Genome 10:906–912.
   PubMedGoogle Scholar
• Hendrich, B., and A. Bird. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18:6538–6547.
   PubMed Web of Science ®Google Scholar
• Hendrich, B., and A. Bird. 2000. Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation. Curr. Top. Microbiol. Immunol. 249:55–74.
   PubMed Web of Science ®Google Scholar
• Hendrich, B., U. Hardeland, H. H. Ng, J. Jiricny, and A. Bird. 1999. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401:301–304.
   PubMed Web of Science ®Google Scholar
• Hsieh, C. L. 1994. Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14:5487–5494.
   PubMed Web of Science ®Google Scholar
• Hu, X., J. Bi, H. H. Loh, and L. N. Wei. 2001. An intronic Ikaros-binding element mediates retinoic acid suppression of the kappa opioid receptor gene, accompanied by histone deacetylation on the promoters. J. Biol. Chem. 276:4597–4603.
   PubMed Web of Science ®Google Scholar
• Hwang, C. K., C. S. Kim, H. S. Choi, S. R. McKercher, and H. H. Loh. 2004. Transcriptional regulation of mouse mu opioid receptor gene by PU 1. J. Biol. Chem. 279:19764–19774.
   PubMed Web of Science ®Google Scholar
• Hwang, C. K., X. Wu, G. Wang, C. S. Kim, and H. H. Loh. 2003. Mouse mu opioid receptor distal promoter transcriptional regulation by SOX proteins. J. Biol. Chem. 278:3742–3750.
   PubMedGoogle Scholar
• Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074–1080.
   PubMed Web of Science ®Google Scholar
• Jones, P. L., G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass, N. Landsberger, J. Strouboulis, and A. P. Wolffe. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:187–191.
   PubMed Web of Science ®Google Scholar
• Jones-Villeneuve, E. M., M. W. McBurney, K. A. Rogers, and V. I. Kalnins. 1982. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell Biol. 94:253–262.
   PubMed Web of Science ®Google Scholar
• Kazama, H., T. Kodera, S. Shimizu, H. Mizoguchi, and K. Morishita. 1999. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation. Cell Growth Differ. 10:565–573.
   PubMedGoogle Scholar
• Kieffer, B. L., and C. J. Evans. 2002. Opioid tolerance—in search of the holy grail. Cell 108:587–590.
   PubMed Web of Science ®Google Scholar
• Kim, C. S., H. S. Choi, C. K. Hwang, K. Y. Song, B. K. Lee, P. Y. Law, L. N. Wei, and H. H. Loh. 2006. Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res. 34:6392–6403.
   PubMed Web of Science ®Google Scholar
• Kim, C. S., C. K. Hwang, H. S. Choi, K. Y. Song, P. Y. Law, L. N. Wei, and H. H. Loh. 2004. Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J. Biol. Chem. 279:46464–46473.
   PubMedGoogle Scholar
• Klose, R. J., and A. P. Bird. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31:89–97.
   PubMed Web of Science ®Google Scholar
• Klose, R. J., S. A. Sarraf, L. Schmiedeberg, S. M. McDermott, I. Stancheva, and A. P. Bird. 2005. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 19:667–678.
   PubMedGoogle Scholar
• Ko, J. L., H. C. Chen, and H. H. Loh. 2002. Differential promoter usage of mouse mu-opioid receptor gene during development. Brain Res. Mol. Brain Res. 104:184–193.
   PubMedGoogle Scholar
• Ko, J. L., H. C. Liu, S. R. Minnerath, and H. H. Loh. 1998. Transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 273:27678–27685.
   PubMedGoogle Scholar
• Ko, J. L., S. R. Minnerath, and H. H. Loh. 1997. Dual promoters of mouse mu-opioid receptor gene. Biochem. Biophys. Res. Commun. 234:351–357.
   PubMedGoogle Scholar
• Kraus, J., C. Borner, E. Giannini, and V. Hollt. 2003. The role of nuclear factor κB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol. Pharmacol. 64:876–884.
   PubMed Web of Science ®Google Scholar
• Kraus, J., G. Horn, A. Zimprich, T. Simon, P. Mayer, and V. Hollt. 1995. Molecular cloning and functional analysis of the rat mu opioid receptor gene promoter. Biochem. Biophys. Res. Commun. 215:591–597.
   PubMedGoogle Scholar
• Lachner, M., and T. Jenuwein. 2002. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14:286–298.
   PubMed Web of Science ®Google Scholar
• Lachner, M., D. O'Carroll, S. Rea, K. Mechtler, and T. Jenuwein. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410:116–120.
   PubMed Web of Science ®Google Scholar
• Law, P. Y., Y. H. Wong, and H. H. Loh. 2000. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40:389–430.
   PubMedGoogle Scholar
• Li, E., T. H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915–926.
   PubMed Web of Science ®Google Scholar
• Li, J., S. W. Park, H. H. Loh, and L. N. Wei. 2002. Induction of the mouse kappa-opioid receptor gene by retinoic acid in P19 cells. J. Biol. Chem. 277:39967–39972.
   PubMedGoogle Scholar
• Lyu, J., F. Costantini, E. H. Jho, and C. K. Joo. 2003. Ectopic expression of Axin blocks neuronal differentiation of embryonic carcinoma P19 cells. J. Biol. Chem. 278:13487–13495.
   PubMed Web of Science ®Google Scholar
• Mansour, A., C. A. Fox, H. Akil, and S. J. Watson. 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:22–29.
   PubMed Web of Science ®Google Scholar
• Martinowich, K., D. Hattori, H. Wu, S. Fouse, F. He, Y. Hu, G. Fan, and Y. E. Sun. 2003. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890–893.
   PubMed Web of Science ®Google Scholar
• McBurney, M. W. 1993. P19 embryonal carcinoma cells. Int. J. Dev. Biol. 37:135–140.
   PubMed Web of Science ®Google Scholar
• McBurney, M. W., E. M. Jones-Villeneuve, M. K. Edwards, and P. J. Anderson. 1982. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299:165–167.
   PubMed Web of Science ®Google Scholar
• McBurney, M. W., K. R. Reuhl, A. I. Ally, S. Nasipuri, J. C. Bell, and J. Craig. 1988. Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J. Neurosci. 8:1063–1073.
   PubMedGoogle Scholar
• Meehan, R. R., J. D. Lewis, S. McKay, E. L. Kleiner, and A. P. Bird. 1989. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58:499–507.
   PubMed Web of Science ®Google Scholar
• Min, B. H., L. B. Augustin, R. F. Felsheim, J. A. Fuchs, and H. H. Loh. 1994. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. USA 91:9081–9085.
   PubMedGoogle Scholar
• Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386–389.
   PubMed Web of Science ®Google Scholar
• Nan, X., P. Tate, E. Li, and A. Bird. 1996. DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol. 16:414–421.
   PubMed Web of Science ®Google Scholar
• Ng, H. H., Y. Zhang, B. Hendrich, C. A. Johnson, B. M. Turner, H. Erdjument-Bromage, P. Tempst, D. Reinberg, and A. Bird. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23:58–61.
   PubMed Web of Science ®Google Scholar
• Oka, M., A. M. Meacham, T. Hamazaki, N. Rodic, L. J. Chang, and N. Terada. 2005. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine. Oncogene 24:3091–3099.
   PubMed Web of Science ®Google Scholar
• Oka, M., N. Rodic, J. Graddy, L. J. Chang, and N. Terada. 2006. CpG sites preferentially methylated by Dnmt3a in vivo. J. Biol. Chem. 281:9901–9908.
   PubMed Web of Science ®Google Scholar
• Park, S. W., M. D. Huq, H. H. Loh, and L. N. Wei. 2005. Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. J. Neurosci. 25:3350–3357.
   PubMedGoogle Scholar
• Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
   PubMed Web of Science ®Google Scholar
• Prokhortchouk, A., B. Hendrich, H. Jorgensen, A. Ruzov, M. Wilm, G. Georgiev, A. Bird, and E. Prokhortchouk. 2001. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15:1613–1618.
   PubMed Web of Science ®Google Scholar
• Rius, R. A., J. Barg, W. T. Bem, C. J. Coscia, and Y. P. Loh. 1991. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain. Brain Res. Dev. Brain Res. 58:237–241.
   PubMedGoogle Scholar
• Ruzicka, B. B., and H. Akil. 1997. The interleukin-1β-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience 79:517–524.
   PubMedGoogle Scholar
• Sarraf, S. A., and I. Stancheva. 2004. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol. Cell 15:595–605.
   PubMed Web of Science ®Google Scholar
• Shiota, K., Y. Kogo, J. Ohgane, T. Imamura, A. Urano, K. Nishino, S. Tanaka, and N. Hattori. 2002. Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 7:961–969.
   PubMedGoogle Scholar
• Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599–606.
   PubMed Web of Science ®Google Scholar
• Suzuki, S., T. Miyagi, T. K. Chuang, L. F. Chuang, R. H. Doi, and R. Y. Chuang. 2000. Morphine upregulates mu opioid receptors of human and monkey lymphocytes. Biochem. Biophys. Res. Commun. 279:621–628.
   PubMedGoogle Scholar
• Tang, K., J. Yang, X. Gao, C. Wang, L. Liu, H. Kitani, T. Atsumi, and N. Jing. 2002. Wnt-1 promotes neuronal differentiation and inhibits gliogenesis in P19 cells. Biochem. Biophys. Res. Commun. 293:167–173.
   PubMed Web of Science ®Google Scholar
• Wade, P. A. 2001. Methyl CpG-binding proteins and transcriptional repression. Bioessays 23:1131–1137.
   PubMed Web of Science ®Google Scholar
• Wade, P. A., A. Gegonne, P. L. Jones, E. Ballestar, F. Aubry, and A. P. Wolffe. 1999. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23:62–66.
   PubMed Web of Science ®Google Scholar
• Wang, G., T. Liu, L. N. Wei, P. Y. Law, and H. H. Loh. 2005. DNA methylation-related chromatin modification in the regulation of mouse delta-opioid receptor gene. Mol. Pharmacol. 67:2032–2039.
   PubMedGoogle Scholar
• Wang, G., L. N. Wei, and H. H. Loh. 2003. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells. J. Biol. Chem. 278:40550–40556.
   PubMed Web of Science ®Google Scholar
• Watt, F., and P. L. Molloy. 1988. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 2:1136–1143.
   PubMed Web of Science ®Google Scholar
• Wenger, R. H., I. Kvietikova, A. Rolfs, G. Camenisch, and M. Gassmann. 1998. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur. J. Biochem. 253:771–777.
   PubMedGoogle Scholar
• Zegerman, P., B. Canas, D. Pappin, and T. Kouzarides. 2002. Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J. Biol. Chem. 277:11621–11624.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., H. H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird, and D. Reinberg. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1924–1935.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., M. S. Hsu, and J. E. Pintar. 1998. Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J. Neurosci. 18:2538–2549.
   PubMedGoogle Scholar